Quoting from the April 5th GEN (via Biowire):
"The Colorado BioScience Association (CBSA) appointed four new board members at its 2012 Annual All-Member Meeting held at the Westin Westminster, Westminster, CO, yesterday. The announcement is made jointly by Steve Orndorff, Ph.D., Chairperson of the Board of Directors and Holli Riebel, CBSA President & CEO of CBSA.
Newly appointed CBSA board members include:
James Chomas, Ph.D., Founder & CEO, Surefire Medical - Westminster -www.surefiremedical.com
Scott Deeter, President & CEO, Ventria Bioscience - Fort Collins - www.ventria.com
Brent Fassett, Partner, Cooley LLP - Broomfield - www.cooley.com
Kerry Ingalls,Vice President of Colorado Operations, Amgen - Boulder/Longmont - www.amgen.com
Riebel says: 'CBSA’s board is a prestigious group of industry leaders comprised of representatives of biotechnology, medical device, diagnostic, pharmaceutical, health care providers, research institutions and those businesses that provide critical services and products to bioscience companies. Board members commit to a three-year term to support CBSA’s mission to support the regional bioscience community through advocacy, resources and advancement of opportunities for collaboration. CBSA board members work in partnership with staff to support the drive and determination of over 600 Colorado bioscience companies that work to improve lives locally and around the world.'"
Link to GEN